Clinical characteristics |
|
Sex (male/female), n |
10/4 |
Age (y), mean and range |
59.6 ±10.7 (39–80) |
Interval between SPE presentation and admission, n (%) |
|
Day of admission |
10 (71%) |
≤ 3 days after admission |
4 (29%) |
Presented symptoms, n (%) |
|
Fever |
14 (100%) |
Shortness of breath |
8 (57%) |
Cough |
5 (36%) |
General weakness |
5 (36%) |
Altered mental status |
2 (14%) |
Hemoptysis |
2 (14%) |
Right upper quadrant abdominal pain |
1 (7%) |
Comorbidities, n (%) |
|
Diabetes mellitus |
12 (86%) |
Hypertension |
2 (14%) |
Cerebrovascular disease |
1 (7%) |
Laboratory data, n (%) |
|
White blood cell count > 10,000 cells/mm3
|
9 (64%) |
Serum creatinine level > 1.5 mg/dL |
8 (57%) |
Serum alanine transaminase level > 40 IU/mL |
6 (43%) |
Liver abscess location, n (%) |
|
Right lobe |
9 (64%) |
Left lobe |
4 (29%) |
Both lobes |
1 (7%) |
Computed tomographic findings |
|
Feeding vessel sign |
11 (79%) |
Nodule |
|
Without cavity |
11 (79%) |
With cavity |
11 (79%) |
Peripheral wedge-shaped opacity |
9 (64%) |
Patchy ground-glass opacity |
7 (50%) |
Air bronchograms within a nodule |
5 (36%) |
Focal consolidation |
3 (21%) |
Halo sign |
2 (14%) |
Lung abscess |
2 (14%) |
Pleural effusion |
|
Bilateral |
4 (29%) |
Right |
4 (29%) |
Left |
2 (14%) |
Lesions in |
|
Bilateral lungs |
12 (86%) |
Right lung |
2 (14%) |
Clinical courses |
|
Antibiotic therapy, n (%) |
|
Ceftriaxone combined with metronidazole |
10 (71%) |
Carbapenem |
3 (21%) |
Piperacillin/tazobactam |
1 (7%) |
Surgical procedures, n (%) |
|
Pigtail catheter drainage of liver abscess |
10 (71%) |
Tube thoracostomy |
2 (14%) |
Video-assisted thoracostomy with decortication |
1 (7%) |
Complications, n (%) |
|
Acute kidney injury |
8 (57%) |
Septic shock |
6 (43%) |
Acute respiratory failure |
5 (36%) |
Length of stay in hospital (d), mean and range |
20.9 ± 21.1 (8–42) |
Mortality, n (%) |
2 (14%) |